Insider Transactions Reported by 18 Insiders of Editas Medicine, Inc.

Symbol
EDIT on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Editas Medicine, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
MICHELLE ROBERTSON Evp, Chief Financial Officer $1,161,750 11 May 2023
Bruce Eaton Evp, Cbo And Cto $815,012 05 Dec 2023
Mark Shearman Evp, Chief Scientific Officer $714,410 13 Feb 2023
Gilmore O'Neill CEO, Director $579,371 -$81,229 -12% 03 Dec 2025
Baisong Mei Evp, Chief Medical Officer $277,003 03 Dec 2024
Lisa Michaels EVP/Chief Medical Officer $247,094 22 Dec 2021
Erick Lucera Evp, Chief Financial Officer $192,841 -$7,030 -3.5% 08 Mar 2025
Linda Burkly Evp, Chief Scientific Officer $148,083 -$22,333 -13% 03 Dec 2025
Amy Parison SVP, Chief Financial Officer $34,251 -$4,702 -12% 03 Dec 2025
Emma Reeve Director 30 May 2024
Meeta Chatterjee Director 30 May 2024
David Scadden Director 06 Jun 2025
Akshay Vaishnaw Director 30 May 2024
MULLEN JAMES C CEO, Director 14 Apr 2022
Bernadette Connaughton Director 06 Jun 2025
Andrew Hirsch Director 06 Jun 2025
Elliott Levy Director 06 Jun 2025
Jessica Hopfield Director 06 Jun 2025

Recent Insider Transactions by Companies or Individuals for Editas Medicine, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.